Focused multivector ultraviolet (FMUV) technology rapidly eradicates SARS-CoV-2 in-vitro: Implications for hospital disinfection of COVID-19 environments. Academic Article uri icon

Overview

abstract

  • Focused Multivector Ultraviolet technology rapidly killed the SARS-CoV-2 coronavirus in-vitro. Plates were inoculated with a mean of greater than 106 plaque forming units of USA-WA1 Washington index patient strain of SARS-CoV-2 and exposed to ultraviolet, resulting in mean reductions of 99.99% within 30 seconds, 99.999% within 60 seconds, and 99.9999% within 90 seconds. These results support the effectiveness of Focused Multivector Ultraviolet technology for SARS-CoV-2 disinfection.

publication date

  • February 11, 2022

Research

keywords

  • COVID-19
  • SARS-CoV-2

Identity

PubMed Central ID

  • PMC8830925

Scopus Document Identifier

  • 85128155796

Digital Object Identifier (DOI)

  • 10.1016/j.ajic.2022.02.001

PubMed ID

  • 35151772

Additional Document Info

volume

  • 50

issue

  • 7